| Date | Shareholder name | Reason of Disclosure | Buy/Sell and Involved Shares |
Average Price per share | Current Holdings | % of Issued Shares |
| 09/09/2026 | Qu Jiguang | 1113(L) | +880,000(L) | HKD2.731(L) | 1,266,522,000(L) | 42.91 |
| 09/09/2026 | China Pharmaceutical Company Limited | 1101(L) | +880,000(L) | HKD2.731(L) | 915,634,000(L) | 31.02 |
| 08/09/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,300,000(L) | HKD2.708(L) | 914,754,000(L) | 30.99 |
| 08/09/2026 | Qu Jiguang | 1113(L) | +1,300,000(L) | HKD2.708(L) | 1,265,642,000(L) | 42.88 |
| 07/09/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD2.744(L) | 913,454,000(L) | 30.95 |
| 07/09/2026 | Qu Jiguang | 1113(L) | +1,000,000(L) | HKD2.744(L) | 1,264,342,000(L) | 42.84 |
| 04/09/2026 | China Pharmaceutical Company Limited | 1710(L) | +850,000(L) | HKD2.751(L) | 912,454,000(L) | 30.91 |
| 04/09/2026 | Qu Jiguang | 1113(L) | +850,000(L) | HKD2.751(L) | 1,263,342,000(L) | 42.80 |
| 24/06/2026 | UBS Group AG | 1213(L) | -4,574,000(L) | 172,627,945(L) 32,758,602(S) | 5.85 1.11 | |
| 15/06/2026 | UBS Group AG | 1316(L) | 5,278,184(L) | 181,882,945(L) 32,723,602(S) | 6.16 1.11 | |
| 22/05/2026 | UBS Group AG | 1402(S) | +417,000(S) | 191,143,845(L) 29,636,502(S) | 6.48 1.00 | |
| 21/05/2026 | Qu Jiguang | 1113(L) | +1,300,000(L) | HKD2.373(L) | 1,262,492,000(L) | 42.78 |
| 20/05/2026 | Qu Jiguang | 1113(L) | +2,000,000(L) | HKD2.313(L) | 1,261,192,000(L) | 42.73 |
| 19/05/2026 | Qu Jiguang | 1113(L) | +2,000,000(L) | HKD2.353(L) | 1,259,192,000(L) | 42.66 |
| 18/05/2026 | Qu Jiguang | 1113(L) | +2,500,000(L) | HKD2.330(L) | 1,257,192,000(L) | 42.60 |
| 05/05/2026 | Qu Jiguang | 1113(L) | +1,100,000(L) | HKD2.353(L) | 1,254,692,000(L) | 42.51 |
| 05/05/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,100,000(L) | HKD2.353(L) | 911,604,000(L) | 30.89 |
| 17/04/2026 | Qu Jiguang | 1113(L) | +1,450,000(L) | HKD2.497(L) | 1,253,592,000(L) | 42.48 |
| 17/04/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,450,000(L) | HKD2.497(L) | 910,504,000(L) | 30.85 |
| 16/04/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,450,000(L) | HKD2.512(L) | 909,054,000(L) | 30.80 |
| 16/04/2026 | Qu Jiguang | 1113(L) | +1,450,000(L) | HKD2.512(L) | 1,252,142,000(L) | 42.43 |
| 10/04/2026 | China Pharmaceutical Company Limited | 1710(L) | +1,800,000(L) | HKD2.545(L) | 907,604,000(L) | 30.75 |
| 10/04/2026 | Qu Jiguang | 1113(L) | +1,800,000(L) | HKD2.545(L) | 1,250,692,000(L) | 42.38 |
| 09/04/2026 | China Pharmaceutical Company Limited | 1710(L) | +3,000,000(L) | HKD2.515(L) | 905,804,000(L) | 30.69 |
| 09/04/2026 | Qu Jiguang | 1113(L) | +3,000,000(L) | HKD2.515(L) | 1,248,892,000(L) | 42.32 |
| 08/04/2026 | China Pharmaceutical Company Limited | 1710(L) | +4,200,000(L) | HKD2.512(L) | 902,804,000(L) | 30.59 |
| 08/04/2026 | Qu Jiguang | 1113(L) | +4,200,000(L) | HKD2.512(L) | 1,245,892,000(L) | 42.21 |
| 01/04/2026 | China Pharmaceutical Company Limited | 1710(L) | +4,300,000(L) | HKD2.513(L) | 898,604,000(L) | 30.45 |
| 01/04/2026 | Qu Jiguang | 1113(L) | +4,300,000(L) | HKD2.513(L) | 1,241,692,000(L) | 42.07 |
| 31/03/2026 | UBS Group AG | 1113(L) | +5,097,022(L) | 180,934,736(L) | 6.13 | |
| 31/03/2026 | China Pharmaceutical Company Limited | 1710(L) | +4,100,000(L) | HKD2.511(L) | 894,304,000(L) | 30.30 |
| 31/03/2026 | Qu Jiguang | 1113(L) | +4,100,000(L) | HKD2.511(L) | 1,237,392,000(L) | 41.93 |
| 27/03/2026 | Meng Guo | 1711(L) | -20,000,000(L) | 0(L) | 0.00 | |
| 27/03/2026 | UBS Group AG | 1314(L) | 1,784,000(L) | 167,710,802(L) | 5.68 | |
| 27/03/2026 | Chow Hing Yeung | 1711(L) | -2,000,000(L) | 0(L) | 0.00 | |
| 19/03/2026 | 1711(L) | 468,296,000(L) | 680,686,000(L) | 23.07 | ||
| 10/03/2026 | UBS Group AG | 1213(L) | -13,317,171(L) | 165,156,131(L) | 5.60 | |
| 05/03/2026 | UBS Group AG | 1313(L) | 7,980,000(L) | 184,640,893(L) | 6.26 | |
| 27/02/2026 | UBS Group AG | 1313(L) | 6,104,000(L) | 185,008,997(L) | 6.27 | |
| 25/02/2026 | UBS Group AG | 1313(L) | 3,224,900(L) | 184,940,486(L) | 6.27 | |
| 1 2 3 4 | ||||||
| Remark: | (L) - Long Position, (S) - Short Position, (P) Lending; |
| Real time quote last updated: 10/09/2026 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |